Content area

Abstract

Arthritis has a high global prevalence. During the early ancient human era, bee (Apis) venom therapy was employed in Egypt, Greece, and China to alleviate ailments such as arthritis and neuralgia. In addition, bee venom has long been used as a traditional medicine for immune-related diseases in Korea. Wasp (Vespa) venom is a folk medicine of the Jingpo people in Yunnan, China, and has been widely used to treat rheumatoid arthritis. In spite of this, the underlying mechanisms of bee and wasp venoms for the treatment of arthritis are yet to be fully understood. In recent years, researchers have investigated the potential anti-arthritic properties of bee and wasp venoms. Studies have shown that both bee and wasp venom can improve swelling, pain, and inflammation caused by arthritis. The difference is that bee venom reduces arthritis damage to bone and cartilage by inhibiting the IRAK2/TAK1/NF-κB signaling pathway, NF-κB signaling pathway, and JAK/STAT signaling pathway, as well as decreasing osteoclastogenesis by inhibiting the RANKL/RANK signaling pathway. Wasp venom, on the other hand, regulates synovial cell apoptosis via the Bax/Bcl-2 signaling pathway, inhibits the JAK/STAT signaling pathway to reduce inflammation production, and also ameliorates joint inflammation by regulating redox balance and iron death in synovial cells. This review provides a detailed overview of the various types of arthritis and their current therapeutic approaches; additionally, it comprehensively analyzes the therapeutic properties of bee venom, wasp venom, or venom components used as anti-arthritic drugs and explores their mechanisms of action in anti-arthritic therapy.

Details

1009240
Title
Therapeutic Potential of Bee and Wasp Venom in Anti-Arthritic Treatment: A Review
Author
Sun, Hongmei 1 ; Qu, Yunxia 1 ; Lei, Xiaojing 1 ; Xu, Qingzhu 1 ; Li, Siming 1 ; Shi, Zhengmei 1 ; Xiao, Huai 1 ; Zhang, Chenggui 2 ; Yang, Zhibin 2   VIAFID ORCID Logo 

 Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali 671000, China; [email protected] (H.S.); [email protected] (Y.Q.); [email protected] (X.L.); [email protected] (Q.X.); [email protected] (S.L.); [email protected] (Z.S.); [email protected] (H.X.) 
 Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali 671000, China; [email protected] (H.S.); [email protected] (Y.Q.); [email protected] (X.L.); [email protected] (Q.X.); [email protected] (S.L.); [email protected] (Z.S.); [email protected] (H.X.); National-Local Joint Engineering Research Center of Entomoceutics, Dali 671000, China 
Publication title
Toxins; Basel
Volume
16
Issue
11
First page
452
Publication year
2024
Publication date
2024
Publisher
MDPI AG
Place of publication
Basel
Country of publication
Switzerland
Publication subject
e-ISSN
20726651
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2024-10-22
Milestone dates
2024-09-03 (Received); 2024-10-13 (Accepted)
Publication history
 
 
   First posting date
22 Oct 2024
ProQuest document ID
3133128229
Document URL
https://www.proquest.com/scholarly-journals/therapeutic-potential-bee-wasp-venom-anti/docview/3133128229/se-2?accountid=208611
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-04-01
Database
ProQuest One Academic